These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 25501107)
1. The association of nm23-H1 expression with a poor prognosis in patients with peripheral T-cell lymphoma, not otherwise specified. Niitsu N J Clin Exp Hematop; 2014; 54(3):171-7. PubMed ID: 25501107 [TBL] [Abstract][Full Text] [Related]
2. [Expression and clinical significance of nm23-H1 and MUC-1 in peripheral T-cell lymphoma]. Huang HQ; Pan ZH; Lin XB; Wang BF; Hou JH; Zhang Y; Wu QL Ai Zheng; 2006 Dec; 25(12):1517-23. PubMed ID: 17166378 [TBL] [Abstract][Full Text] [Related]
3. Expression of nm23-H1 is associated with poor prognosis in peripheral T-cell lymphoma. Niitsu N; Nakamine H; Okamoto M; Akamatsu H; Honma Y; Higashihara M; Okabe-Kado J; Hirano M; Br J Haematol; 2003 Nov; 123(4):621-30. PubMed ID: 14616965 [TBL] [Abstract][Full Text] [Related]
4. nm23-H1 protein expression and gene mutation in 150 patients with non-Hodgkin's lymphomas. Lee JH; Cho SJ; Zhang X; Zheng Z; Lee ES; Kim A; Kim YS; Chae YS; Kim I J Korean Med Sci; 2006 Aug; 21(4):645-51. PubMed ID: 16891807 [TBL] [Abstract][Full Text] [Related]
5. Expression of nm23-H1 is associated with poor prognosis in peripheral T-cell lymphoma, not otherwise specified. Niitsu N; Nakamine H; Okamoto M Clin Cancer Res; 2011 May; 17(9):2893-9. PubMed ID: 21478336 [TBL] [Abstract][Full Text] [Related]
6. Prognostic implications of the differentiation inhibitory factor nm23-H1 protein in the plasma of aggressive non-Hodgkin's lymphoma. Niitsu N; Okabe-Kado J; Kasukabe T; Yamamoto-Yamaguchi Y; Umeda M; Honma Y Blood; 1999 Nov; 94(10):3541-50. PubMed ID: 10552965 [TBL] [Abstract][Full Text] [Related]
7. Clinical significance of nm23-H1 proteins expressed on cell surface in non-Hodgkin's lymphoma. Niitsu N; Honma Y; Iijima K; Takagi T; Higashihara M; Sawada U; Okabe-Kado J Leukemia; 2003 Jan; 17(1):196-202. PubMed ID: 12529678 [TBL] [Abstract][Full Text] [Related]
8. Clinical significance of intracytoplasmic nm23-H1 expression in diffuse large B-cell lymphoma. Niitsu N; Nakamine H; Okamoto M; Akamatsu H; Higashihara M; Honma Y; Okabe-Kado J; Hirano M Clin Cancer Res; 2004 Apr; 10(7):2482-90. PubMed ID: 15073128 [TBL] [Abstract][Full Text] [Related]
9. Clinicopathological features of programmed cell death-1 and programmed cell death-ligand-1 expression in the tumor cells and tumor microenvironment of angioimmunoblastic T cell lymphoma and peripheral T cell lymphoma not otherwise specified. Kim S; Kwon D; Koh J; Nam SJ; Kim YA; Kim TM; Kim CW; Jeon YK Virchows Arch; 2020 Jul; 477(1):131-142. PubMed ID: 32170448 [TBL] [Abstract][Full Text] [Related]
10. Serum nm23-H1 protein as a prognostic factor in hematological malignancies. Okabe-Kado J Leuk Lymphoma; 2002 Apr; 43(4):859-67. PubMed ID: 12153176 [TBL] [Abstract][Full Text] [Related]
11. Serum nm23-H1 protein as a prognostic factor in aggressive non-Hodgkin lymphoma. Niitsu N; Okabe-Kado J; Okamoto M; Takagi T; Yoshida T; Aoki S; Hirano M; Honma Y Blood; 2001 Mar; 97(5):1202-10. PubMed ID: 11222361 [TBL] [Abstract][Full Text] [Related]
16. A clinicopathological study of nm23-H1 expression in classical Hodgkin's lymphoma. Niitsu N; Nakamine H; Okamoto M; Tamaru JI; Hirano M Ann Oncol; 2008 Nov; 19(11):1941-6. PubMed ID: 18647967 [TBL] [Abstract][Full Text] [Related]
17. A study on nm23-H1 expression in diffuse large B-cell lymphoma that was treated with CyclOBEAP plus rituximab therapy. Niitsu N; Tamaru J; Yoshino T; Nakamura N; Nakamura S; Ohshima K; Nakamine H; Okamoto M Ann Hematol; 2011 Feb; 90(2):185-92. PubMed ID: 20809421 [TBL] [Abstract][Full Text] [Related]
18. Clinical and prognostic differences between ALK-negative anaplastic large cell lymphoma and peripheral T cell lymphoma, not otherwise specified: a single institution experience. Deng XW; Zhang XM; Wang WH; Wang SL; Jin J; Fang H; Ren H; Liu YP; He XH; Dong M; Song YW; Li YX Ann Hematol; 2016 Aug; 95(8):1271-80. PubMed ID: 27209536 [TBL] [Abstract][Full Text] [Related]
19. Serum nm23-H1 protein as a prognostic factor for indolent non-Hodgkin's lymphoma. Niitsu N; Okamoto M; Okabe-Kado J; Takagi T; Yoshida T; Aoki S; Honma Y; Hirano M Leukemia; 2001 May; 15(5):832-9. PubMed ID: 11368446 [TBL] [Abstract][Full Text] [Related]
20. Serum IgA level, monocyte count, and international prognostic index are independently associated with overall survival in patients with HTLV-I-negative nodal peripheral T cell lymphoma. Kato A; Imai Y; Aoki K; Tabata S; Matsushita A; Hashimoto H; Takahashi T; Ishikawa T Ann Hematol; 2014 Jul; 93(7):1185-91. PubMed ID: 24526138 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]